S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling.
Acta Pharm Sin B. 2021 Mar;11(3):668-679. doi: 10.1016/j.apsb.2020.11.006. Epub 2020 Nov 13.
Acta Pharm Sin B. 2021.
PMID: 33777674
Free PMC article.